XML 24 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash Flow from Operating Activities:      
Net income (loss) $ 144,827 $ 146,024 $ 148,498
Less: loss attributable to noncontrolling interests 262 217 217
Net income attributable to The GEO Group, Inc. 145,089 146,241 148,715
Adjustments to reconcile net income attributable to The GEO Group, Inc. to net cash provided by (used in) operating activities:      
Depreciation and amortization expense 126,434 124,297 114,916
Deferred tax provision (benefit) 1,230 12,238 (5,963)
Amortization of debt issuance costs, discount and/or premium and other non-cash interest 8,856 16,540 12,121
Stock-based compensation 22,049 19,844 12,773
Loss on extinguishment of debt 0 0 15,885
Provision for doubtful accounts 823 2,456 2,682
Equity in earnings of affiliates, net of tax (9,627) (12,045) (6,925)
Income tax deficiency (benefit) related to equity compensation 0 0 1,626
Loss (gain) on sale/disposal of property and equipment 4,236 1,520 394
Dividends received from unconsolidated joint venture 11,846 6,132 1,611
Changes in assets and liabilities, net of acquisition:      
Changes in accounts receivable, prepaid expenses and other assets (66,101) 20,938 (50,946)
Changes in contract receivable (2,049) 40,515 (280,562)
Changes in accounts payable, accrued expenses and other liabilities 31,689 2,366 5,645
Net cash provided by (used in) operating activities 274,475 381,042 (28,028)
Cash Flow from Investing Activities:      
Acquisition of CEC, cash consideration, net of cash acquired 0 (353,556) 0
Proceeds from sale of property and equipment 2,077 3,460 2,030
Insurance proceeds - damaged property 1,438 2,754 4,733
Proceeds from sale of assets held for sale 3,797 0 0
Change in restricted cash and investments (129) (4,507) (2,892)
Capital expenditures (195,666) (148,406) (81,565)
Net cash used in investing activities (188,483) (500,255) (77,694)
Cash Flow from Financing Activities:      
Payments on long-term debt (282,358) (1,140,788) (934,006)
Proceeds from long term debt 502,998 1,389,084 1,012,945
Payments on non-recourse debt (18,544) (307,414) (10,064)
Proceeds from non-recourse debt 0 181,658 266,835
Taxes paid related to net share settlements of equity awards (3,820) (4,142) (2,336)
Debt issuance costs (990) (9,542) (21,115)
Payments for purchase of treasury shares (95,175) 0 0
Proceeds from stock options exercised 1,887 6,962 3,347
Income tax (deficiency) benefit related to equity compensation 0 0 (1,626)
Proceeds from issuance of common stock in connection with ESPP 534 497 436
Issuance of common stock in connection with public offering 0 275,867 0
Dividends paid (229,498) (227,463) (194,748)
Net cash (used in) provided by financing activities (124,966) 164,719 119,668
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (10,099) (2,318) 1,119
Net (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash and Cash Equivalents (49,073) 43,188 15,065
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, beginning of period 133,545 90,357 75,292
Cash, Cash Equivalents and Restricted Cash and Cash Equivalents, end of period 84,472 133,545 90,357
Cash paid during the year for:      
Income taxes 8,035 13,809 23,063
Interest 133,566 115,354 109,356
Non-cash investing and financing activities:      
Capital expenditures in accounts payable and accrued expenses $ 15,253 $ 13,039 $ 894